Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition.
Saved in:
| Title: | Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition. |
|---|---|
| Authors: | Moedt E; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Koshino A; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Nephrology and Rheumatology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan., Jongs N; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Ju W; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Nair V; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Kretzler M; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Hansen MK; Janssen Research and Development, LLC, Spring House, Pennsylvania., Arnott CG; The George Institute for Global Health, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Wheeler DC; Department of Renal Medicine, University College London, London, United Kingdom., Rossing P; Steno Diabetes Center Copenhagen, Herlev, Denmark., Coca SG; Icahn School of Medicine at Mount Sinai, New York, New York., Hammarstedt A; Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Greasley PJ; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Bjornstad P; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, Washington., Bakker SJL; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. |
| Source: | Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2026 Apr 02. Date of Electronic Publication: 2026 Apr 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41926219 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Moedt+E%22">Moedt E</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Koshino+A%22">Koshino A</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Nephrology and Rheumatology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.<br /><searchLink fieldCode="AU" term="%22Jongs+N%22">Jongs N</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ju+W%22">Ju W</searchLink>; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Nair+V%22">Nair V</searchLink>; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Kretzler+M%22">Kretzler M</searchLink>; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Hansen+MK%22">Hansen MK</searchLink>; Janssen Research and Development, LLC, Spring House, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Arnott+CG%22">Arnott CG</searchLink>; The George Institute for Global Health, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Wheeler+DC%22">Wheeler DC</searchLink>; Department of Renal Medicine, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rossing+P%22">Rossing P</searchLink>; Steno Diabetes Center Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Coca+SG%22">Coca SG</searchLink>; Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Hammarstedt+A%22">Hammarstedt A</searchLink>; Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Greasley+PJ%22">Greasley PJ</searchLink>; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Bjornstad+P%22">Bjornstad P</searchLink>; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Bakker+SJL%22">Bakker SJL</searchLink>; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Heerspink+HJL%22">Heerspink HJL</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229013836%22">Journal of the American Society of Nephrology : JASN</searchLink> [J Am Soc Nephrol] 2026 Apr 02. <i>Date of Electronic Publication: </i>2026 Apr 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+on+behalf+of+the+American+Society+of+Nephrology%22">Wolters Kluwer Health, on behalf of the American Society of Nephrology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9013836 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-3450 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210466673%22">10466673 </searchLink><i>NLM ISO Abbreviation: </i>J Am Soc Nephrol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41926219 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1681/ASN.0000001086 Languages: – Code: eng Text: English Titles: – TitleFull: Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Moedt E – PersonEntity: Name: NameFull: Koshino A – PersonEntity: Name: NameFull: Jongs N – PersonEntity: Name: NameFull: Ju W – PersonEntity: Name: NameFull: Nair V – PersonEntity: Name: NameFull: Kretzler M – PersonEntity: Name: NameFull: Hansen MK – PersonEntity: Name: NameFull: Arnott CG – PersonEntity: Name: NameFull: Wheeler DC – PersonEntity: Name: NameFull: Rossing P – PersonEntity: Name: NameFull: Coca SG – PersonEntity: Name: NameFull: Hammarstedt A – PersonEntity: Name: NameFull: Greasley PJ – PersonEntity: Name: NameFull: Bjornstad P – PersonEntity: Name: NameFull: Bakker SJL – PersonEntity: Name: NameFull: Heerspink HJL IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 04 Text: 2026 Apr 02 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1533-3450 Titles: – TitleFull: Journal of the American Society of Nephrology : JASN Type: main |
| ResultId | 1 |